Targeting Hedgehog pathway in pediatric acute myeloid leukemia: challenges and opportunities
- PMID: 30556755
- DOI: 10.1080/14728222.2019.1559822
Targeting Hedgehog pathway in pediatric acute myeloid leukemia: challenges and opportunities
Keywords: Hedgehog pathway; pediatric acute myeloid leukemia; refractory acute myeloid leukemia; target therapy.
Similar articles
-
Targeting of the Hedgehog pathway in myeloid malignancies: still a worthy chase?Br J Haematol. 2015 Aug;170(3):323-35. doi: 10.1111/bjh.13426. Epub 2015 Apr 19. Br J Haematol. 2015. PMID: 25892100 Review.
-
Hedgehog pathway inhibition as a therapeutic target in acute myeloid leukemia.Expert Rev Anticancer Ther. 2019 Aug;19(8):717-729. doi: 10.1080/14737140.2019.1652095. Epub 2019 Aug 17. Expert Rev Anticancer Ther. 2019. PMID: 31422721 Review.
-
Emerging therapeutic targets for the treatment of human acute myeloid leukemia (part 1) - gene transcription, cell cycle regulation, metabolism and intercellular communication.Expert Rev Hematol. 2015 Jun;8(3):299-313. doi: 10.1586/17474086.2015.1032935. Epub 2015 Apr 3. Expert Rev Hematol. 2015. PMID: 25835070 Review.
-
[European approvals: Glasdegib for Acute myeloid leukemia].Bull Cancer. 2020 Dec;107(12):1206-1207. doi: 10.1016/j.bulcan.2020.09.006. Epub 2020 Oct 15. Bull Cancer. 2020. PMID: 33070952 French. No abstract available.
-
NANOG Expression as a Responsive Biomarker during Treatment with Hedgehog Signal Inhibitor in Acute Myeloid Leukemia.Int J Mol Sci. 2017 Feb 24;18(3):486. doi: 10.3390/ijms18030486. Int J Mol Sci. 2017. PMID: 28245563 Free PMC article.
Cited by
-
A 69 long noncoding RNA signature predicts relapse and acts as independent prognostic factor in pediatric AML.Blood Adv. 2024 Jun 25;8(12):3299-3310. doi: 10.1182/bloodadvances.2024012667. Blood Adv. 2024. PMID: 38640434 Free PMC article.
-
Targeted Therapies for Pediatric AML: Gaps and Perspective.Front Pediatr. 2019 Nov 15;7:463. doi: 10.3389/fped.2019.00463. eCollection 2019. Front Pediatr. 2019. PMID: 31803695 Free PMC article. Review.
-
Chidamide Inhibits Glioma Cells by Increasing Oxidative Stress via the miRNA-338-5p Regulation of Hedgehog Signaling.Oxid Med Cell Longev. 2020 Mar 11;2020:7126976. doi: 10.1155/2020/7126976. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32256960 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical